Physician

Musa R Abdelaziz, MD

According to 2025 Medicare claims, Musa Abdelaziz, MD (NPI: 1588906465) practices ophthalmology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is JAWAD A QURESHI MD PA (NPI: 1881994713; TIN: 27-3557509) and primary practice location at 76092-1352.

Abdelaziz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 732 traditional Medicare patients, billed 19,269 HCPCS/CPT codes, and received $1,233,854 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 680 prescription claims across 220 beneficiaries totaling $22,190 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 30 records totaling $771. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,001 to $1,233,854. Similarly, Part D prescription costs have risen steadily, from $3,791 to $22,190. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$617K$1.2M2017 Medicare payment: $28,001 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $80,418 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $26,813 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $24,279 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $230,379 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $497,213 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $764,249 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,233,854 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017131415$28,001
2018385954$80,418
2019163233$26,813
202061205$24,279
20212971,821$230,379
20223893,358$497,213
202355212,601$764,249
202473219,269$1,233,854

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$33K2015 Drug cost: $3,791 (USD; Tot_Drug_Cst)2016 Drug cost: $1,288 (USD; Tot_Drug_Cst)2017 Drug cost: $5,078 (USD; Tot_Drug_Cst)2018 Drug cost: $8,657 (USD; Tot_Drug_Cst)2019 Drug cost: $5,415 (USD; Tot_Drug_Cst)2020 Drug cost: $1,971 (USD; Tot_Drug_Cst)2021 Drug cost: $10,603 (USD; Tot_Drug_Cst)2022 Drug cost: $16,275 (USD; Tot_Drug_Cst)2023 Drug cost: $32,906 (USD; Tot_Drug_Cst)2024 Drug cost: $22,190 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152441$3,791
20161740$1,288
20172146$5,078
201863134$8,657
20194186$5,415
20201956$1,971
202158173$10,603
2022123356$16,275
2023170528$32,906
2024220680$22,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more227227$122
67028Injection of drug into eye164736$95
92014Established patient complete exam of visual system6071,576$94
92134Imaging of retina7121,828$31
92201Extended exam of the back part of the eye with retinal drawing156168$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2146,414$7,458
MoxifloxacinMoxifloxacin Hcl1061,284$2,661
Ketorolac TromethamineKetorolac Tromethamine933,028$2,552
Brimonidine TartrateBrimonidine Tartrate251,996$2,158
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat1027,340$839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$771ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Musa R. Abdelaziz, MD?

Tedicare shows public-source Medicare data for Musa R. Abdelaziz, MD (NPI 1588906465), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Musa R. Abdelaziz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Musa R. Abdelaziz, MD?

Musa R. Abdelaziz, MD is linked to JAWAD A QURESHI MD PA (billing NPI 1881994713) in the available physician profile data.

Does Musa R. Abdelaziz, MD have Open Payments data?

Musa R. Abdelaziz, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.